| C028474 | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene | "1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of NQO2 mRNA" | 28903501 |
| C445701 | 1-benzyl-1,4-dihydronicotinamide | "chrysoeriol inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Ubiquinone Q2]" | 20399199 |
| C445701 | 1-benzyl-1,4-dihydronicotinamide | "chrysoeriol inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Vitamin K 3]" | 20399199 |
| C445701 | 1-benzyl-1,4-dihydronicotinamide | "Melatonin inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Ubiquinone Q2]" | 20399199 |
| C445701 | 1-benzyl-1,4-dihydronicotinamide | "Melatonin inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Vitamin K 3]" | 20399199 |
| C445701 | 1-benzyl-1,4-dihydronicotinamide | "N-(2-(2-methoxy-6H-dipyrido(2,3-a-3,2-e)pyrrolizin-11-yl)ethyl)-2-furamide inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Ubiquinone Q2]" | 20399199 |
| C445701 | 1-benzyl-1,4-dihydronicotinamide | "N-(2-(2-methoxy-6H-dipyrido(2,3-a-3,2-e)pyrrolizin-11-yl)ethyl)-2-furamide inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Vitamin K 3]" | 20399199 |
| C445701 | 1-benzyl-1,4-dihydronicotinamide | "NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide" | 20399199 |
| C445701 | 1-benzyl-1,4-dihydronicotinamide | "[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of 2,6-Dichloroindophenol" | 20399199 |
| C445701 | 1-benzyl-1,4-dihydronicotinamide | "[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Ubiquinone Q1" | 20399199 |
| C445701 | 1-benzyl-1,4-dihydronicotinamide | "[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Ubiquinone Q2" | 20399199 |
| C445701 | 1-benzyl-1,4-dihydronicotinamide | "[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Vitamin K 3" | 20399199 |
| C445701 | 1-benzyl-1,4-dihydronicotinamide | "resveratrol inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Ubiquinone Q2]" | 20399199 |
| C445701 | 1-benzyl-1,4-dihydronicotinamide | "resveratrol inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Vitamin K 3]" | 20399199 |
| C051246 | 1-methylanthracene | [1-methylanthracene co-treated with fluoranthene] results in decreased expression of NQO2 mRNA | 28329830 |
| C029497 | 2,3-bis(3'-hydroxybenzyl)butyrolactone | "[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NQO2 mRNA" | 19167446 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of NQO2 mRNA" | 28433925 |
| C016403 | 2,4-dinitrotoluene | "2,4-dinitrotoluene affects the expression of NQO2 mRNA" | 21346803 |
| C009505 | 4,4'-diaminodiphenylmethane | "4,4'-diaminodiphenylmethane results in increased expression of NQO2 mRNA" | 18648102 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NQO2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NQO2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NQO2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NQO2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NQO2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NQO2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NQO2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NQO2 mRNA" | 27188386 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of NQO2 mRNA | 17562736 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 affects the expression of NQO2 protein | 20106945 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased methylation of NQO2 gene | 27153756 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased expression of NQO2 mRNA | 19770486 |
| D000517 | alpha-Chlorohydrin | alpha-Chlorohydrin results in increased expression of NQO2 mRNA | 28522335 |
| D000966 | Antimony Potassium Tartrate | Antimony Potassium Tartrate results in increased expression of NQO2 mRNA | 28713220 |
| D034341 | Aristolochic Acids | Aristolochic Acids results in decreased expression of NQO2 mRNA | 19717638 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of NQO2 mRNA | 21461292 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in increased expression of NQO2 mRNA | 19737606 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of NQO2 mRNA | 20106945|2163298 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of NQO2 mRNA | 20127859 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of NQO2 mRNA | 21715664 |
| D001564 | Benzo(a)pyrene | "[lipopolysaccharide, E coli O55-B5 co-treated with Benzo(a)pyrene] affects the expression of NQO2 mRNA" | 28987381 |
| D004958 | Estradiol | Estradiol results in increased expression of NQO2 mRNA | 19167446 |
| C006780 | bisphenol A | "[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of NQO2 mRNA" | 28433925 |
| C006780 | bisphenol A | bisphenol A affects the expression of NQO2 mRNA | 25181051 |
| D000069286 | Bortezomib | Bortezomib results in increased expression of NQO2 mRNA | 20977926 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in decreased expression of NQO2 mRNA | 15336504 |
| D002211 | Capsaicin | Capsaicin inhibits the reaction [Dietary Fats results in increased expression of NQO2 protein] | 20359164 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased expression of NQO2 mRNA | 27339419 |
| C007054 | chrysoeriol | "chrysoeriol inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Ubiquinone Q2]" | 20399199 |
| C007054 | chrysoeriol | "chrysoeriol inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Vitamin K 3]" | 20399199 |
| C007054 | chrysoeriol | chrysoeriol inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Ubiquinone Q2] | 20399199 |
| C007054 | chrysoeriol | chrysoeriol inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Vitamin K 3] | 20399199 |
| D003024 | Clozapine | NQO2 gene SNP affects the susceptibility to Clozapine | 14617031 |
| D003042 | Cocaine | Cocaine results in increased expression of NQO2 mRNA | 17898221 |
| D019327 | Copper Sulfate | Copper Sulfate results in increased expression of NQO2 mRNA | 19549813 |
| D003375 | Coumestrol | "[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NQO2 mRNA" | 19167446 |
| D003375 | Coumestrol | [Coumestrol co-treated with resveratrol] results in increased expression of NQO2 mRNA | 19167446 |
| D003375 | Coumestrol | Coumestrol results in increased expression of NQO2 mRNA | 19167446 |
| D016572 | Cyclosporine | Cyclosporine results in decreased expression of NQO2 mRNA | 25562108 |
| D016572 | Cyclosporine | Cyclosporine results in increased expression of NQO2 mRNA | 20106945|2798913 |
| D016572 | Cyclosporine | Cyclosporine results in decreased expression of NQO2 mRNA | 19770486 |
| D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in decreased expression of NQO2 mRNA | 21266533 |
| D002945 | Cisplatin | Cisplatin results in increased expression of NQO2 mRNA | 21151649 |
| D004041 | Dietary Fats | Capsaicin inhibits the reaction [Dietary Fats results in increased expression of NQO2 protein] | 20359164 |
| D004041 | Dietary Fats | Dietary Fats results in increased expression of NQO2 protein | 20359164 |
| D004051 | Diethylhexyl Phthalate | "[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of NQO2 mRNA" | 28433925 |
| D004128 | Dimethylnitrosamine | Dimethylnitrosamine results in decreased expression of NQO2 mRNA | 25380136 |
| D004317 | Doxorubicin | Doxorubicin results in decreased expression of NQO2 mRNA | 25896364 |
| C118739 | entinostat | entinostat results in increased expression of NQO2 mRNA | 26272509 |
| C118739 | entinostat | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NQO2 mRNA" | 27188386 |
| C500988 | estradiol-3,4-quinone | "estradiol-3,4-quinone binds to NQO2 protein" | 18996184 |
| C500988 | estradiol-3,4-quinone | "NQO2 protein results in increased reduction of estradiol-3,4-quinone" | 18996184 |
| C500988 | estradiol-3,4-quinone | "Quercetin inhibits the reaction [NQO2 protein results in increased reduction of estradiol-3,4-quinone]" | 18996184 |
| C007738 | fluoranthene | [1-methylanthracene co-treated with fluoranthene] results in decreased expression of NQO2 mRNA | 28329830 |
| D005485 | Flutamide | Flutamide results in decreased expression of NQO2 mRNA | 24136188 |
| D017313 | Fenretinide | Fenretinide results in decreased expression of NQO2 mRNA | 28973697 |
| D006861 | Hydrogen Peroxide | [Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of NQO2 protein | 18951874 |
| C492448 | ICG 001 | ICG 001 results in increased expression of NQO2 mRNA | 26191083 |
| D000068877 | Imatinib Mesylate | Imatinib Mesylate results in decreased activity of NQO2 protein | 21859103 |
| D007545 | Isoproterenol | Isoproterenol results in decreased expression of NQO2 mRNA | 21335049 |
| C544151 | jinfukang | jinfukang results in increased expression of NQO2 mRNA | 27392435 |
| C008261 | lead acetate | lead acetate results in decreased expression of NQO2 mRNA | 22641619 |
| C482199 | lipopolysaccharide, E coli O55-B5 | "[lipopolysaccharide, E coli O55-B5 co-treated with Benzo(a)pyrene] affects the expression of NQO2 mRNA" | 28987381 |
| D008550 | Melatonin | Melatonin affects the activity of NQO2 protein | 22289031 |
| D008550 | Melatonin | "Melatonin inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Ubiquinone Q2]" | 20399199 |
| D008550 | Melatonin | "Melatonin inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Vitamin K 3]" | 20399199 |
| D008550 | Melatonin | Melatonin inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Ubiquinone Q2] | 20399199 |
| D008550 | Melatonin | Melatonin inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Vitamin K 3] | 20399199 |
| D008550 | Melatonin | Melatonin binds to NQO2 protein | 17762829 |
| D008550 | Melatonin | Melatonin results in decreased activity of NQO2 protein | 21859103 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of NQO2 mRNA | 20713471 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in increased expression of NQO2 mRNA | 28001369 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in decreased expression of NQO2 mRNA | 20061341 |
| D008741 | Methyl Methanesulfonate | Methyl Methanesulfonate results in increased expression of NQO2 mRNA | 23649840 |
| C406082 | monomethylarsonous acid | monomethylarsonous acid results in increased expression of NQO2 protein | 24625837 |
| C550454 | N-(2-(2-methoxy-6H-dipyrido(2,3-a-3,2-e)pyrrolizin-11-yl)ethyl)-2-furamide | "N-(2-(2-methoxy-6H-dipyrido(2,3-a-3,2-e)pyrrolizin-11-yl)ethyl)-2-furamide inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Ubiquinone Q2]" | 20399199 |
| C550454 | N-(2-(2-methoxy-6H-dipyrido(2,3-a-3,2-e)pyrrolizin-11-yl)ethyl)-2-furamide | "N-(2-(2-methoxy-6H-dipyrido(2,3-a-3,2-e)pyrrolizin-11-yl)ethyl)-2-furamide inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Vitamin K 3]" | 20399199 |
| C550454 | N-(2-(2-methoxy-6H-dipyrido(2,3-a-3,2-e)pyrrolizin-11-yl)ethyl)-2-furamide | "N-(2-(2-methoxy-6H-dipyrido(2,3-a-3,2-e)pyrrolizin-11-yl)ethyl)-2-furamide inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Ubiquinone Q2]" | 20399199 |
| C550454 | N-(2-(2-methoxy-6H-dipyrido(2,3-a-3,2-e)pyrrolizin-11-yl)ethyl)-2-furamide | "N-(2-(2-methoxy-6H-dipyrido(2,3-a-3,2-e)pyrrolizin-11-yl)ethyl)-2-furamide inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Vitamin K 3]" | 20399199 |
| C550454 | N-(2-(2-methoxy-6H-dipyrido(2,3-a-3,2-e)pyrrolizin-11-yl)ethyl)-2-furamide | "N-(2-(2-methoxy-6H-dipyrido(2,3-a-3,2-e)pyrrolizin-11-yl)ethyl)-2-furamide inhibits the reaction [Paraquat results in increased activity of NQO2 protein]" | 22289031 |
| C550454 | N-(2-(2-methoxy-6H-dipyrido(2,3-a-3,2-e)pyrrolizin-11-yl)ethyl)-2-furamide | "N-(2-(2-methoxy-6H-dipyrido(2,3-a-3,2-e)pyrrolizin-11-yl)ethyl)-2-furamide results in decreased activity of NQO2 protein" | 22289031 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in decreased expression of NQO2 mRNA" | 25620056 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in decreased expression of NQO2 mRNA" | 25620056 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in increased expression of NQO2 mRNA" | 25554681 |
| C051752 | nefazodone | nefazodone results in decreased expression of NQO2 mRNA | 24136188 |
| C029938 | nickel sulfate | nickel sulfate results in increased expression of NQO2 mRNA | 22714537 |
| C018613 | nicotinamide-beta-riboside | chrysoeriol inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Ubiquinone Q2] | 20399199 |
| C018613 | nicotinamide-beta-riboside | chrysoeriol inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Vitamin K 3] | 20399199 |
| C018613 | nicotinamide-beta-riboside | Melatonin inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Ubiquinone Q2] | 20399199 |
| C018613 | nicotinamide-beta-riboside | Melatonin inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Vitamin K 3] | 20399199 |
| C018613 | nicotinamide-beta-riboside | "N-(2-(2-methoxy-6H-dipyrido(2,3-a-3,2-e)pyrrolizin-11-yl)ethyl)-2-furamide inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Ubiquinone Q2]" | 20399199 |
| C018613 | nicotinamide-beta-riboside | "N-(2-(2-methoxy-6H-dipyrido(2,3-a-3,2-e)pyrrolizin-11-yl)ethyl)-2-furamide inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Vitamin K 3]" | 20399199 |
| C018613 | nicotinamide-beta-riboside | NQO2 protein results in increased oxidation of nicotinamide-beta-riboside | 20399199 |
| C018613 | nicotinamide-beta-riboside | "[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of 2,6-Dichloroindophenol" | 20399199 |
| C018613 | nicotinamide-beta-riboside | [NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Ubiquinone Q1 | 20399199 |
| C018613 | nicotinamide-beta-riboside | [NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Ubiquinone Q2 | 20399199 |
| C018613 | nicotinamide-beta-riboside | [NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Vitamin K 3 | 20399199 |
| C018613 | nicotinamide-beta-riboside | resveratrol inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Ubiquinone Q2] | 20399199 |
| C018613 | nicotinamide-beta-riboside | resveratrol inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Vitamin K 3] | 20399199 |
| C025589 | ochratoxin A | ochratoxin A results in decreased expression of NQO2 mRNA | 19717638 |
| C030110 | oxaliplatin | [oxaliplatin co-treated with Topotecan] results in increased expression of NQO2 mRNA | 25729387 |
| C496932 | panobinostat | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NQO2 mRNA" | 27188386 |
| C496932 | panobinostat | panobinostat results in increased expression of NQO2 mRNA | 26272509 |
| D010269 | Paraquat | "N-(2-(2-methoxy-6H-dipyrido(2,3-a-3,2-e)pyrrolizin-11-yl)ethyl)-2-furamide inhibits the reaction [Paraquat results in increased activity of NQO2 protein]" | 22289031 |
| D010269 | Paraquat | NQO2 protein results in increased susceptibility to Paraquat | 22289031 |
| D010269 | Paraquat | Paraquat results in increased activity of NQO2 protein | 22289031 |
| C568608 | PCI 5002 | [PCI 5002 co-treated with Zinc] results in increased expression of NQO2 mRNA | 18593933 |
| C101814 | perfluoro-n-undecanoic acid | perfluoro-n-undecanoic acid results in decreased expression of NQO2 mRNA | 23602845 |
| D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NQO2 mRNA" | 27188386 |
| D010662 | Phenylmercuric Acetate | Phenylmercuric Acetate results in increased expression of NQO2 mRNA | 26272509 |
| C006253 | pirinixic acid | pirinixic acid results in decreased expression of NQO2 mRNA | 18445702 |
| D011441 | Propylthiouracil | Propylthiouracil results in decreased expression of NQO2 mRNA | 24780913 |
| C107773 | pterostilbene | pterostilbene results in increased expression of NQO2 mRNA | 24936659 |
| C107773 | pterostilbene | pterostilbene results in increased expression of NQO2 protein | 24936659 |
| C513428 | pyrachlostrobin | pyrachlostrobin results in increased expression of NQO2 mRNA | 27029645 |
| D011794 | Quercetin | Quercetin binds to NQO2 protein | 15350128 |
| D011794 | Quercetin | "Quercetin inhibits the reaction [NQO2 protein results in increased reduction of estradiol-3,4-quinone]" | 18996184 |
| D011794 | Quercetin | Quercetin results in decreased expression of NQO2 mRNA | 21632981 |
| C059514 | resveratrol | [Coumestrol co-treated with resveratrol] results in increased expression of NQO2 mRNA | 19167446 |
| C059514 | resveratrol | NQO2 protein inhibits the reaction [resveratrol results in decreased expression of AKT1 protein] | 24968355 |
| C059514 | resveratrol | NQO2 protein promotes the reaction [resveratrol results in decreased expression of BCL2 protein] | 19661309 |
| C059514 | resveratrol | NQO2 protein promotes the reaction [resveratrol results in decreased expression of RELA protein] | 19661309 |
| C059514 | resveratrol | resveratrol analog results in decreased activity of NQO2 protein | 23953689 |
| C059514 | resveratrol | resveratrol binds to and results in decreased activity of NQO2 protein | 15350128|2395368 |
| C059514 | resveratrol | resveratrol binds to NQO2 protein | 24968355 |
| C059514 | resveratrol | [resveratrol binds to NQO2 protein] inhibits the reaction [NQO2 protein binds to AKT1 protein] | 24968355 |
| C059514 | resveratrol | resveratrol inhibits the reaction [AKT1 protein binds to NQO2 protein] | 24968355 |
| C059514 | resveratrol | "resveratrol inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Ubiquinone Q2]" | 20399199 |
| C059514 | resveratrol | "resveratrol inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Vitamin K 3]" | 20399199 |
| C059514 | resveratrol | resveratrol inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Ubiquinone Q2] | 20399199 |
| C059514 | resveratrol | resveratrol inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Vitamin K 3] | 20399199 |
| C059514 | resveratrol | resveratrol results in increased expression of and affects the localization of NQO2 protein | 16759640 |
| C059514 | resveratrol | resveratrol results in increased expression of NQO2 protein | 15993843 |
| C059514 | resveratrol | resveratrol binds to NQO2 protein modified form | 23953689 |
| C059514 | resveratrol | resveratrol results in decreased activity of NQO2 protein | 17762829|2185910 |
| D015474 | Isotretinoin | Isotretinoin results in decreased expression of NQO2 mRNA | 20436886 |
| D012524 | Sarin | Sarin results in decreased expression of NQO2 mRNA | 19522546 |
| D012601 | Scopolamine Hydrobromide | Scopolamine Hydrobromide results in increased expression of NQO2 mRNA | 20861374 |
| D012822 | Silicon Dioxide | Silicon Dioxide results in decreased expression of NQO2 mRNA | 23221170 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of NQO2 mRNA | 22714537|2451658 |
| D015086 | 2,6-Dichloroindophenol | "[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of 2,6-Dichloroindophenol" | 20399199 |
| D015086 | 2,6-Dichloroindophenol | "[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of 2,6-Dichloroindophenol" | 20399199 |
| D012969 | Sodium Fluoride | Sodium Fluoride results in increased expression of NQO2 protein | 28918527 |
| C016766 | sulforafan | sulforafan results in increased expression of NQO2 mRNA | 26833863 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of NQO2 mRNA | 20106945|2163298 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of NQO2 protein | 11154737 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of NQO2 mRNA | 21570461 |
| D013749 | Tetrachlorodibenzodioxin | "[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of NQO2 mRNA" | 28433925 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to NQO2 promoter] | 21889950 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of NQO2 mRNA | 21889950 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of NQO2 mRNA | 18796159|2121527 |
| D013755 | Tetradecanoylphorbol Acetate | [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of NQO2 mRNA | 16979875 |
| D013792 | Thalidomide | Thalidomide results in decreased expression of NQO2 mRNA | 26217789 |
| D013806 | Theophylline | [Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of NQO2 protein | 18951874 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased expression of NQO2 mRNA | 22363418 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased expression of NQO2 mRNA | 28111298 |
| D019772 | Topotecan | [oxaliplatin co-treated with Topotecan] results in increased expression of NQO2 mRNA | 25729387 |
| D019772 | Topotecan | Topotecan results in increased expression of NQO2 mRNA | 25729387 |
| D014212 | Tretinoin | Tretinoin results in increased expression of NQO2 mRNA | 20488242 |
| C012589 | trichostatin A | trichostatin A affects the expression of NQO2 mRNA | 28542535 |
| C012589 | trichostatin A | trichostatin A results in increased expression of NQO2 mRNA | 24935251 |
| C057693 | troglitazone | troglitazone results in decreased expression of NQO2 mRNA | 28973697 |
| C025203 | Ubiquinone Q1 | "[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Ubiquinone Q1" | 20399199 |
| C025203 | Ubiquinone Q1 | [NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Ubiquinone Q1 | 20399199 |
| C025204 | Ubiquinone Q2 | "chrysoeriol inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Ubiquinone Q2]" | 20399199 |
| C025204 | Ubiquinone Q2 | chrysoeriol inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Ubiquinone Q2] | 20399199 |
| C025204 | Ubiquinone Q2 | "Melatonin inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Ubiquinone Q2]" | 20399199 |
| C025204 | Ubiquinone Q2 | Melatonin inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Ubiquinone Q2] | 20399199 |
| C025204 | Ubiquinone Q2 | "N-(2-(2-methoxy-6H-dipyrido(2,3-a-3,2-e)pyrrolizin-11-yl)ethyl)-2-furamide inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Ubiquinone Q2]" | 20399199 |
| C025204 | Ubiquinone Q2 | "N-(2-(2-methoxy-6H-dipyrido(2,3-a-3,2-e)pyrrolizin-11-yl)ethyl)-2-furamide inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Ubiquinone Q2]" | 20399199 |
| C025204 | Ubiquinone Q2 | "[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Ubiquinone Q2" | 20399199 |
| C025204 | Ubiquinone Q2 | [NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Ubiquinone Q2 | 20399199 |
| C025204 | Ubiquinone Q2 | "resveratrol inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Ubiquinone Q2]" | 20399199 |
| C025204 | Ubiquinone Q2 | resveratrol inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Ubiquinone Q2] | 20399199 |
| D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NQO2 mRNA" | 27188386 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of NQO2 mRNA | 25979313 |
| D014635 | Valproic Acid | Valproic Acid results in decreased methylation of NQO2 gene | 29154799 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of NQO2 mRNA | 23179753|2438349 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of NQO2 mRNA | 17292431 |
| C025643 | vinclozolin | vinclozolin results in decreased expression of NQO2 mRNA | 22615374 |
| D024483 | Vitamin K 3 | "chrysoeriol inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Vitamin K 3]" | 20399199 |
| D024483 | Vitamin K 3 | chrysoeriol inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Vitamin K 3] | 20399199 |
| D024483 | Vitamin K 3 | "Melatonin inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Vitamin K 3]" | 20399199 |
| D024483 | Vitamin K 3 | Melatonin inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Vitamin K 3] | 20399199 |
| D024483 | Vitamin K 3 | "N-(2-(2-methoxy-6H-dipyrido(2,3-a-3,2-e)pyrrolizin-11-yl)ethyl)-2-furamide inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Vitamin K 3]" | 20399199 |
| D024483 | Vitamin K 3 | "N-(2-(2-methoxy-6H-dipyrido(2,3-a-3,2-e)pyrrolizin-11-yl)ethyl)-2-furamide inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Vitamin K 3]" | 20399199 |
| D024483 | Vitamin K 3 | "[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Vitamin K 3" | 20399199 |
| D024483 | Vitamin K 3 | [NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Vitamin K 3 | 20399199 |
| D024483 | Vitamin K 3 | "resveratrol inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Vitamin K 3]" | 20399199 |
| D024483 | Vitamin K 3 | resveratrol inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Vitamin K 3] | 20399199 |
| D024483 | Vitamin K 3 | NQO2 affects the susceptibility to Vitamin K 3 | 12351651 |
| D024483 | Vitamin K 3 | NQO2 gene mutant form results in decreased susceptibility to Vitamin K 3 | 21859103 |
| D024483 | Vitamin K 3 | NQO2 protein results in increased activity of Vitamin K 3 | 17762829 |
| C111237 | vorinostat | vorinostat results in increased expression of NQO2 protein | 17593366 |
| D015032 | Zinc | [PCI 5002 co-treated with Zinc] results in increased expression of NQO2 mRNA | 18593933 |
| D015032 | Zinc | Zinc affects the expression of NQO2 mRNA | 16979875 |
| D015032 | Zinc | [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of NQO2 mRNA | 16979875 |